| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.03 | 0.6 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.6 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.6 |